Royce & Associates’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-3,157
Closed -$36K 1107
2020
Q2
$36K Buy
3,157
+287
+10% +$3.27K ﹤0.01% 1065
2020
Q1
$41K Buy
2,870
+796
+38% +$11.4K ﹤0.01% 1032
2019
Q4
$56K Sell
2,074
-191,088
-99% -$5.16M ﹤0.01% 1026
2019
Q3
$5.53M Buy
193,162
+15,664
+9% +$448K 0.05% 465
2019
Q2
$4.93M Buy
177,498
+35,267
+25% +$980K 0.04% 492
2019
Q1
$4.72M Buy
142,231
+131,246
+1,195% +$4.36M 0.04% 519
2018
Q4
$319K Sell
10,985
-56,788
-84% -$1.65M ﹤0.01% 956
2018
Q3
$3.12M Buy
67,773
+225
+0.3% +$10.4K 0.02% 716
2018
Q2
$2.52M Buy
67,548
+116
+0.2% +$4.33K 0.02% 775
2018
Q1
$1.99M Buy
67,432
+40,043
+146% +$1.18M 0.01% 856
2017
Q4
$941K Buy
27,389
+34
+0.1% +$1.17K 0.01% 984
2017
Q3
$990K Buy
+27,355
New +$990K 0.01% 967
2016
Q4
Sell
-90,369
Closed -$1.86M 1096
2016
Q3
$1.86M Sell
90,369
-847,129
-90% -$17.4M 0.01% 824
2016
Q2
$28.7M Sell
937,498
-347,200
-27% -$10.6M 0.19% 156
2016
Q1
$48.1M Sell
1,284,698
-130,200
-9% -$4.87M 0.3% 87
2015
Q4
$61.1M Sell
1,414,898
-856,770
-38% -$37M 0.36% 64
2015
Q3
$85.1M Sell
2,271,668
-551,535
-20% -$20.7M 0.45% 40
2015
Q2
$96M Sell
2,823,203
-580,997
-17% -$19.7M 0.41% 53
2015
Q1
$121M Sell
3,404,200
-1,680,363
-33% -$59.5M 0.46% 43
2014
Q4
$173M Sell
5,084,563
-3,821,502
-43% -$130M 0.6% 22
2014
Q3
$344M Sell
8,906,065
-393,413
-4% -$15.2M 1.16% 3
2014
Q2
$362M Sell
9,299,478
-136,235
-1% -$5.3M 1.08% 3
2014
Q1
$323M Sell
9,435,713
-1,407,362
-13% -$48.1M 0.95% 6
2013
Q4
$227M Sell
10,843,075
-163,500
-1% -$3.43M 0.65% 17
2013
Q3
$259M Buy
11,006,575
+262,180
+2% +$6.16M 0.77% 9
2013
Q2
$289M Buy
+10,744,395
New +$289M 0.89% 9